Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney. - Wikidata - wikimedia - TriplyDB

Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney.

Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney.

http://www.wikidata.org/entity/Q30486662

about

Gene therapy for radioprotection.Comment on: A model for prediction of cisplatin induced nephrotoxicity by kidney weight in experimental rats.Metformin and diabetic kidney disease: a mini-review on recent findings.Renoprotective effects of metformin.Kidney tubular cell protection; recent findings.Erythropoietin Enhanced Recovery After Traumatic Nerve Injury: Myelination and Localized Effects Erythropoietin and renal protection.Protection of renal tubular cells by antioxidants: current knowledge and new trends.Comment on: preventive effect of Teucrium polium on learning and memory deficits in diabetic rats.Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients Comment on: Protective Role of Recombinant Human Erythropoietin in Kidney and Lung Injury Following Renal Bilateral Ischemia-reperfusion in Rat Model.

P2860

Q36170038-01AF3FD8-1A36-4A25-89AF-58FFA3505FCD Q37537005-28D8C052-D5BF-4C86-81E9-DDD983671B24 Q38385061-6C452806-4B31-4203-AE7A-3B3C1B164CC1 Q40858344-ECA791A4-48B4-467A-8D3C-B6DB2FFE9F9B Q41033363-E35315A4-8F79-46A4-A52A-FC19938B6D5C Q41648362-51203111-F405-4C5C-BD48-A3A9CD0159BB Q41845825-8C3436F3-4865-4912-9C05-21205DA6E7F6 Q41988153-2DD6ADA9-5860-4E16-B4C6-3D7573DFB2BA Q42540723-7632E773-D769-4402-91CE-5E430B8CF345 Q42788390-AC753D66-7B45-478E-8396-5F268304E6F8 Q42861429-19FEDC6F-69CD-4547-A302-4CBD67963B9B

P2860

Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney.

http://www.wikidata.org/entity/Q30486662

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Use of high-dose erythropoieti ...... outcomes in heart and kidney.

@ast

Use of high-dose erythropoieti ...... outcomes in heart and kidney.

@en

type

label

Use of high-dose erythropoieti ...... outcomes in heart and kidney.

@ast

Use of high-dose erythropoieti ...... outcomes in heart and kidney.

@en

prefLabel

Use of high-dose erythropoieti ...... outcomes in heart and kidney.

@ast

Use of high-dose erythropoieti ...... outcomes in heart and kidney.

@en

P1433

Q30486662-E7A43611-E517-4C8F-AEC2-91D5D6C34FB4

P1476

Q30486662-1C35A411-E6A0-473E-8695-A3A497C1D8FD

P2093

Q30486662-10E9397A-B0FE-4E9D-BCA6-21BE0FE2239C

Q30486662-2CA7F1D5-6A0B-4EF3-9E18-7749EF9F42A3

P2860

Q30486662-01A6D567-602C-4ED3-9E83-F2EF4740F940

Q30486662-0DED46F0-8AB5-4A34-820B-F1DB3751F21A

Q30486662-0E33E149-37D3-4A56-B1E4-1BCCC05730B4

Q30486662-0F5819DB-5386-4FF2-8645-F6BC2EEFAD08

Q30486662-10F2DDDD-FDDF-402E-890D-09E76AB40CEA

Q30486662-173C2299-957E-47F1-BF9B-589C7EBAF6A3

Q30486662-18E527A4-D731-45A4-B1F5-01E682BC787D

Q30486662-214E3CE1-965F-4979-9C0C-3F0D493DB98E

Q30486662-21D1D525-0594-4515-8E90-3D2BFBC1149D

Q30486662-24241594-1B2B-45A8-AF2B-F7534FBDA443

P304

Q30486662-947E5063-AA41-455C-9E36-30D02B837616

P31

Q30486662-687C8F06-9B4A-4B01-85D0-3E8D20E781E8

P356

Q30486662-AA0C0FDF-C40B-463A-8F57-1B395C3CC27A

P433

Q30486662-6167603A-0FF1-436A-8BC5-920118582B07

P478

Q30486662-C7C7B03D-7A60-4EE6-81A8-A27302B24F0E

P50

Q30486662-1FE9BFE9-8614-4A63-AC60-2C38C5260CDD

Q30486662-E008CACD-59D5-407C-9FF6-81B96594258C

P577

Q30486662-1FF1831D-EE1A-4D4C-ABBB-036A7EB74686

P5875

Q30486662-5F3FFFED-8D07-488D-8C5B-F0F2192FE54C

P698

Q30486662-2D61C82B-3962-477D-BBCD-260DD4D103BE

P921

Q30486662-E37D05DF-AA32-4DAB-A1CE-590189493032

P932

Q30486662-BC0B4CB4-60FA-4009-993C-EC13A5E9A4B0

P356

P1433

Journal of nephropathology

P1476

Use of high-dose erythropoieti ...... outcomes in heart and kidney.

@en

P2093

David W Johnson

http://www.w3.org/2001/XMLSchema#string

Glenda C Gobe

http://www.w3.org/2001/XMLSchema#string

P2860

A novel role for erythropoietin during fibrin-induced wound-healing response

Science review: recombinant human erythropoietin in critical illness: a role beyond anemia?

Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress

A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury

Erythropoietin: physiology and pharmacology update.

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades.

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.

Erythropoietin protects against diabetes through direct effects on pancreatic beta cells

Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.

Erythropoietin accelerates functional recovery after peripheral nerve injury.

P304

154-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12860/JNP.2013.27

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Christudas Morais

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259961660

http://www.w3.org/2001/XMLSchema#string

P698

24475445

http://www.w3.org/2001/XMLSchema#string

P921

P932

3891135

http://www.w3.org/2001/XMLSchema#string